Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia

Wilhelm Kossenjans, Annie Eis, Rashmi Sahay, Diane Brockman, Leslie Myatt

Research output: Contribution to journalArticle

117 Citations (Scopus)

Abstract

Oxidative stress may increase production of superoxide and nitric oxide, leading to formation of prooxidant peroxynitrite to cause vascular dysfunction. Having found nitrotyrosine residues, a marker of peroxynitrite action, in placental vessels of preeclamptic and diabetic pregnancies, we determined whether vasoreactivity is altered in these placentas and treatment with peroxynitrite produces vascular dysfunction. The responses of diabetic, preeclamptic, and normal placentas to increasing concentrations of the vasoconstrictors U-46619 (10-9-10-7 M) and ANG II (10-9-10-7 M) and the vasodilators glyceryl trinitrate (10-9-10-7 M) and prostacyclin (PGI2; 10-8-10-6 M) were compared as were responses to these agents in normal placentas before and after treatment with 3.16 x 10-4 M peroxynitrite for 30 min. Responses to both vasoconstrictors and vasodilators were significantly attenuated in diabetic and preeclamptic placentas compared with controls. Similarly, responses to U-46619, nitroglycerin, and PGI2, but not ANG II, were significantly attenuated following peroxynitrite treatment. The presence of nitrotyrosine residues confirmed peroxynitrite interaction with placental vessels. Overall, our data suggest that peroxynitrite formation is capable of attenuating vascular responses in the human placenta.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume278
Issue number4 47-4
StatePublished - Apr 2000
Externally publishedYes

Fingerprint

Peroxynitrous Acid
Pre-Eclampsia
Blood Vessels
Placenta
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Nitroglycerin
Vasoconstrictor Agents
Epoprostenol
Vasodilator Agents
Superoxides
Nitric Oxide
Oxidative Stress
Pregnancy

Keywords

  • Nitric oxide
  • Oxidative injury
  • Reactive oxygen species
  • Superoxide

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia. / Kossenjans, Wilhelm; Eis, Annie; Sahay, Rashmi; Brockman, Diane; Myatt, Leslie.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 278, No. 4 47-4, 04.2000.

Research output: Contribution to journalArticle

@article{f9909d761c494652a023142f297f90ff,
title = "Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia",
abstract = "Oxidative stress may increase production of superoxide and nitric oxide, leading to formation of prooxidant peroxynitrite to cause vascular dysfunction. Having found nitrotyrosine residues, a marker of peroxynitrite action, in placental vessels of preeclamptic and diabetic pregnancies, we determined whether vasoreactivity is altered in these placentas and treatment with peroxynitrite produces vascular dysfunction. The responses of diabetic, preeclamptic, and normal placentas to increasing concentrations of the vasoconstrictors U-46619 (10-9-10-7 M) and ANG II (10-9-10-7 M) and the vasodilators glyceryl trinitrate (10-9-10-7 M) and prostacyclin (PGI2; 10-8-10-6 M) were compared as were responses to these agents in normal placentas before and after treatment with 3.16 x 10-4 M peroxynitrite for 30 min. Responses to both vasoconstrictors and vasodilators were significantly attenuated in diabetic and preeclamptic placentas compared with controls. Similarly, responses to U-46619, nitroglycerin, and PGI2, but not ANG II, were significantly attenuated following peroxynitrite treatment. The presence of nitrotyrosine residues confirmed peroxynitrite interaction with placental vessels. Overall, our data suggest that peroxynitrite formation is capable of attenuating vascular responses in the human placenta.",
keywords = "Nitric oxide, Oxidative injury, Reactive oxygen species, Superoxide",
author = "Wilhelm Kossenjans and Annie Eis and Rashmi Sahay and Diane Brockman and Leslie Myatt",
year = "2000",
month = "4",
language = "English (US)",
volume = "278",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "4 47-4",

}

TY - JOUR

T1 - Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia

AU - Kossenjans, Wilhelm

AU - Eis, Annie

AU - Sahay, Rashmi

AU - Brockman, Diane

AU - Myatt, Leslie

PY - 2000/4

Y1 - 2000/4

N2 - Oxidative stress may increase production of superoxide and nitric oxide, leading to formation of prooxidant peroxynitrite to cause vascular dysfunction. Having found nitrotyrosine residues, a marker of peroxynitrite action, in placental vessels of preeclamptic and diabetic pregnancies, we determined whether vasoreactivity is altered in these placentas and treatment with peroxynitrite produces vascular dysfunction. The responses of diabetic, preeclamptic, and normal placentas to increasing concentrations of the vasoconstrictors U-46619 (10-9-10-7 M) and ANG II (10-9-10-7 M) and the vasodilators glyceryl trinitrate (10-9-10-7 M) and prostacyclin (PGI2; 10-8-10-6 M) were compared as were responses to these agents in normal placentas before and after treatment with 3.16 x 10-4 M peroxynitrite for 30 min. Responses to both vasoconstrictors and vasodilators were significantly attenuated in diabetic and preeclamptic placentas compared with controls. Similarly, responses to U-46619, nitroglycerin, and PGI2, but not ANG II, were significantly attenuated following peroxynitrite treatment. The presence of nitrotyrosine residues confirmed peroxynitrite interaction with placental vessels. Overall, our data suggest that peroxynitrite formation is capable of attenuating vascular responses in the human placenta.

AB - Oxidative stress may increase production of superoxide and nitric oxide, leading to formation of prooxidant peroxynitrite to cause vascular dysfunction. Having found nitrotyrosine residues, a marker of peroxynitrite action, in placental vessels of preeclamptic and diabetic pregnancies, we determined whether vasoreactivity is altered in these placentas and treatment with peroxynitrite produces vascular dysfunction. The responses of diabetic, preeclamptic, and normal placentas to increasing concentrations of the vasoconstrictors U-46619 (10-9-10-7 M) and ANG II (10-9-10-7 M) and the vasodilators glyceryl trinitrate (10-9-10-7 M) and prostacyclin (PGI2; 10-8-10-6 M) were compared as were responses to these agents in normal placentas before and after treatment with 3.16 x 10-4 M peroxynitrite for 30 min. Responses to both vasoconstrictors and vasodilators were significantly attenuated in diabetic and preeclamptic placentas compared with controls. Similarly, responses to U-46619, nitroglycerin, and PGI2, but not ANG II, were significantly attenuated following peroxynitrite treatment. The presence of nitrotyrosine residues confirmed peroxynitrite interaction with placental vessels. Overall, our data suggest that peroxynitrite formation is capable of attenuating vascular responses in the human placenta.

KW - Nitric oxide

KW - Oxidative injury

KW - Reactive oxygen species

KW - Superoxide

UR - http://www.scopus.com/inward/record.url?scp=0034016067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034016067&partnerID=8YFLogxK

M3 - Article

VL - 278

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 4 47-4

ER -